Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy

Дата публикации: 21-07-2026 00:00:00

This cohort study compares the outcomes of adult patients undergoing systematic troponin screening with those undergoing clinical assessment alone during immune checkpoint inhibitor (ICI) therapy for cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Cardiotoxicity of Immune Checkpoint Inhibitors	0	8	01-10-2024
2	Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer	0	7.64	01-10-2024
3	Checkpoint Inhibitors Plus Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors	0	4.57	01-09-2023
4	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer	0	10	28-07-2026
5	Cardiac Risk After Heart-Sparing Breast Radiotherapy	0	5	02-07-2026
6	Spectrum of Aldosteronism and Cardiovascular Outcomes	0	6.27	01-04-2026
7	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
8	Circulating Tumor DNA in Early Breast Cancer	0	9.02	01-07-2026
9	Vutrisiran Treatment and Cardiac and Amyloid Changes on MRI	0	5.2	12-08-2026
10	Tissue-Free vs Tumor-Informed Circulating Tumor DNA Assays in Early Triple Negative Breast Cancer	0	12.99	13-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.02. Источник: jamanetwork.com.